$AIP

Viana Antonio J sold $332K of AIP (indirect holdings)

Viana Antonio J sold 8,939 indirectly-held shares of Arteris, Inc. (AIP) at $37.09 ($0.33M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Viana Antonio J
Published Jun 5, 2026, 10:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 10:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider behavior but does not, by itself, indicate new operational or financial developments.

02

Market read

AIP receives a routine insider-selling disclosure; interpret cautiously due to 10b5-1 pre-arrangement.

03

What to watch

Check whether the director’s remaining holdings materially changed versus prior Form 4s; a pattern of repeated sales (not shown here) would be more informative than a single transaction.

Relevance 6/10Novelty 3/10Timing: after-hours/filing disclosure (filed 2026-06-05) following the 2026-06-04 sale

Background

The article reports an SEC Form 4 insider transaction for Arteris, Inc. (AIP): an open-market sale by a director, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Arteris director Viana Antonio J sold 8,939 shares in an open-market transaction disclosed on SEC Form 4.

Expected impact

Likely limited immediate price impact; any move would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is an ownership-change disclosure (not earnings/M&A/clinical/regulatory). The sale is explicitly under a pre-arranged 10b5-1 plan, which reduces interpretive value.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations, so traders may ignore it unless paired with other negative signals.

Key entities

  • Arteris, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Viana Antonio J

    Director who sold 8,939 shares on 2026-06-04 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to